AAAAAA
Results: 1-25/37
Authors:
Pfeffer, MA
Citation: Ma. Pfeffer, New treasures from old ?<Tau Beta > EPHESUS, CARDIO DRUG, 15(1), 2001, pp. 11-13
Authors:
Smith, SC
Blair, SN
Bonow, RO
Brass, LM
Cerqueira, MD
Dracup, K
Fuster, V
Gotto, A
Grundy, SM
Miller, NH
Jacobs, A
Jones, D
Krauss, RM
Mosca, L
Ockene, I
Pasternak, RC
Pearson, T
Pfeffer, MA
Starke, RD
Taubert, KA
Citation: Sc. Smith et al., AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology, J AM COL C, 38(5), 2001, pp. 1581-1583
Authors:
Pfeffer, MA
Citation: Ma. Pfeffer, Tributes to Lewis Dexter, TEX HEART I, 28(3), 2001, pp. 239-239
Authors:
Fischer, TA
Ludwig, S
Flory, E
Gambaryan, S
Singh, K
Finn, P
Pfeffer, MA
Kelly, RA
Pfeffer, JM
Citation: Ta. Fischer et al., Activation of cardiac c-Jun NH2-terminal kinases and p38-mitogen-activatedprotein kinases with abrupt changes in hemodynamic load, HYPERTENSIO, 37(5), 2001, pp. 1222-1228
Authors:
Hennekens, CH
Pfeffer, MA
Citation: Ch. Hennekens et Ma. Pfeffer, The patient with metabolic disorders and/or cardiovascular disease: New and emerging concepts - Introduction, CLIN CARD, 24(7), 2001, pp. II1-II1
Authors:
Pfeffer, MA
Citation: Ma. Pfeffer, Statins: A brief summary, CLIN CARD, 24(7), 2001, pp. II18-II18
Authors:
Smith, SC
Blair, SN
Bonow, RO
Brass, LM
Cerqueira, MD
Dracup, K
Fuster, V
Gotto, A
Grundy, SM
Miller, NH
Jacobs, A
Jones, D
Krauss, RM
Mosca, L
Ockene, I
Pasternak, RC
Pearson, T
Pfeffer, MA
Starke, RD
Taubert, KA
Citation: Sc. Smith et al., AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology, CIRCULATION, 104(13), 2001, pp. 1577-1579
Authors:
Solomon, SD
Glynn, RJ
Greaves, S
Ajani, U
Rouleau, JL
Menapace, F
Arnold, JMO
Hennekens, C
Pfeffer, MA
Citation: Sd. Solomon et al., Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study, ANN INT MED, 134(6), 2001, pp. 451-458
Authors:
Bray, PF
Cannon, CP
Goldschmidt-Clermont, P
Moye, LA
Pfeffer, MA
Sacks, FM
Braunwald, E
Citation: Pf. Bray et al., The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction, AM J CARD, 88(4), 2001, pp. 347-352
Authors:
Pfeffer, MA
Domanski, M
Verter, J
Dunlap, M
Flaker, GC
Gersh, B
Hsia, J
Goldberg, AD
Limacher, MC
Maggioni, AP
Rosenberg, Y
Rouleau, JL
Warnica, JW
Wasserman, AG
Braunwald, E
Citation: Ma. Pfeffer et al., The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial, AM HEART J, 142(3), 2001, pp. 375-377
Authors:
Aikawa, Y
Rohde, L
Plehn, J
Greaves, SC
Menapace, F
Arnold, JM
Rouleau, JL
Pfeffer, MA
Lee, RT
Solomon, SD
Citation: Y. Aikawa et al., Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis, AM HEART J, 141(2), 2001, pp. 234-242
Authors:
Moye, LA
Pfeffer, MA
Citation: La. Moye et Ma. Pfeffer, Attenuation of ventricular enlargement: The SAVE study, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 469-498
Authors:
Pfeffer, JM
Finn, PV
Zornoff, LAM
Pfeffer, MA
Citation: Jm. Pfeffer et al., Endothelin-A receptor antagonism during acute myocardial infarction in rats, CARDIO DRUG, 14(6), 2000, pp. 579-587
Authors:
Rouleau, JL
Pfeffer, MA
Stewart, DJ
Isaac, D
Sestier, F
Kerut, EK
Porter, CB
Proulx, G
Qian, CL
Block, AJ
Citation: Jl. Rouleau et al., Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial, LANCET, 356(9230), 2000, pp. 615-620
Authors:
Sacks, FM
Alaupovic, P
Moye, LA
Cole, TG
Sussex, B
Stampfer, MJ
Pfeffer, MA
Braunwald, E
Citation: Fm. Sacks et al., VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial, CIRCULATION, 102(16), 2000, pp. 1886-1892
Authors:
Shah, MR
Granger, CB
Bart, BA
McMurray, JJV
Petrie, MC
Michelson, EL
Tudor, CE
Swedberg, K
Stevenson, LW
Califf, RM
Pfeffer, MA
Citation: Mr. Shah et al., Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: The Study of Patients Intolerantof Converting Enzyme Inhibitors Registry, AM J MED, 109(6), 2000, pp. 489-492
Authors:
Pfeffer, MA
McMurray, J
Leizorovicz, A
Maggioni, AP
Rouleau, JL
Van de Werf, F
Henis, M
Neuhart, E
Gallo, P
Edwards, S
Sellers, MA
Velazquez, E
Califf, R
Citation: Ma. Pfeffer et al., Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design, AM HEART J, 140(5), 2000, pp. 727-734
Authors:
Granger, CB
Ertl, G
Kuch, J
Maggioni, AP
McMurray, J
Rouleau, JL
Stevenson, LW
Swedberg, K
Young, J
Yusuf, S
Califf, RM
Bart, BA
Held, P
Michelson, EL
Sellers, MA
Ohlin, G
Sparapani, R
Pfeffer, MA
Citation: Cb. Granger et al., Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors, AM HEART J, 139(4), 2000, pp. 609-617
Authors:
Pfeffer, MA
Citation: Ma. Pfeffer, Enhancing cardiac protection after myocardial infarction: Rationale for newer clinical trials of angiotensin receptor blockers, AM HEART J, 139(1), 2000, pp. S23-S28
Authors:
Sacks, FM
Pfeffer, MA
Moye, LA
Hawkins, CM
Davis, BR
Rouleau, JL
Cole, TG
Braunwald, E
Citation: Fm. Sacks et al., Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 63-89
Authors:
Levy, D
Merz, CNB
Cody, RJ
Fouad-Tarazi, FM
Francis, CK
Pfeffer, MA
Scott, NA
Swan, HJC
Taylor, MP
Weinberger, MH
Citation: D. Levy et al., Hypertension detection, treatment and control - A call to action for cardiovascular specialists, J AM COL C, 34(4), 1999, pp. 1360-1362
Authors:
Flaker, GC
Warnica, JW
Sacks, FM
Moye, LA
Davis, BR
Rouleau, JL
Webel, RR
Pfeffer, MA
Braunwald, E
Citation: Gc. Flaker et al., Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations, J AM COL C, 34(1), 1999, pp. 106-112
Authors:
Domanski, MJ
Mitchell, GF
Norman, JE
Exner, DV
Pitt, B
Pfeffer, MA
Citation: Mj. Domanski et al., Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction, J AM COL C, 33(4), 1999, pp. 951-958
Authors:
Domanski, MJ
Exner, DV
Borkowf, CB
Geller, NL
Rosenberg, Y
Pfeffer, MA
Citation: Mj. Domanski et al., Effect of angiotensin converting enzyme inhibition on sudden cardiac deathin patients following acute myocardial infarction - A meta-analysis of randomized clinical trials, J AM COL C, 33(3), 1999, pp. 598-604
Authors:
Rohde, LE
Aikawa, M
Cheng, GC
Sukhova, G
Solomon, SD
Libby, P
Pfeffer, J
Pfeffer, MA
Lee, RT
Citation: Le. Rohde et al., Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction, J AM COL C, 33(3), 1999, pp. 835-842